Susan L. Koppy

Susan L. Koppy is an experienced executive in business development and licensing, currently serving as an Executive Business Development Consultant for multiple companies including Destiny Pharma plc and Tizona Therapeutics, Inc. Since founding SL Koppy Consulting, LLC in 2010, Susan has provided strategic corporate development and licensing advisory services. Previous roles include Head of Business Development & Licensing at Daimedica Therapeutics and Corporate & Business Development Executive at Metacrine, Inc. Susan holds a B.S. in Genetics & Cell Biology from the University of Minnesota, earned between 1980 and 1985.